Citius Pharmaceuticals Inc (CTXR) is lower by Wednesday morning, with the stock declining -5.04% in pre-market trading to 1.13. CTXR's short-term technical score of 77 indicates that the stock has traded more bullishly over the last month than 77% of stocks on the market. In the Biotechnology industry, which ranks 109 out of 146 industries, Citius Pharmaceuticals Inc ranks higher than 79% of stocks. Citius Pharmaceuticals Inc has risen 41.67% over the past month, closing at $0.79 on December 28. During this period of time, the stock fell as low as $0.78 and as high as $1.48. CTXR has an average analyst recommendation of Strong Buy. The company has an average price target of $8.00.
CTXR has an Overall Score of 64. Find out what this means to you and get the rest of the rankings on CTXR!